EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorBo Wang
About this trial
Brain tumors and their surgical treatment may impair cognitive function, affecting patients' quality of life. This prospective single-arm study aims to evaluate the feasibility and clinical utility of an EEG-based neural signal decoding strategy for cognitive function preservation in patients undergoing brain tumor surgery. Participants will undergo standardized neuropsychological assessments together with preoperative, intraoperative, and postoperative electrophysiological recordings. The study will investigate whether EEG-based neural decoding can improve objective cognitive function assessment and support individualized functional preservation during brain tumor surgery.
Eligibility criteria
Qualifiers
Age 18 years to 75 years.
Patients diagnosed with brain glioma and scheduled for surgical treatment.
Conscious and able to understand study procedures.
Able to complete neuropsychological assessments.
Disqualifiers
Severe dysfunction of major organs (heart, lung, liver, or kidney).
Severe psychiatric disorders or cognitive impairment.
Severe language impairment preventing completion of study procedures.
Any other condition judged by the investigator to make participation inappropriate.
Trial design
Treatments tested in this trial
- EEG-Based Neural Signal Decoding Strategy
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Bo Wang
Lead sponsor
Huanhu Hospital Affiliated to Tianjin Medical University
Sponsor institution
Source ClinicalTrials.gov